Visualization of small glottic laryngeal cancer using methyl-labeled 11C-methionine positron emission tomography

Oral Oncology

Volumn 45, Issue 8, 2009, Pages 703-705

  Wedman, J ^a   Pruim, J ^a   Langendijk, J A ^a   van der Laan, B F A M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

11C methionine; Laryngeal cancer; Positron emission tomography

Indexed keywords

11 C METHIONINE; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LARYNX CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; FEMALE; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; MALE; METHIONINE; MIDDLE AGED; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS;

EID: 67650479270     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.10.017     Document Type: Article

References (27)

1. 11C]methionine. Jpn J Cancer Res 80 (1989) 778-782
2. 18F-fluoromethylcholine and 2-deoxy-D-glucose in the distribution of tumor and inflammation. Ann Nucl Med 20 (2006) 527-533
3. Brun E., Kjellen E., Tennvall J., et al. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24 (2002) 127-135
4. 18F-FDG PET: a comparison with conventional methods. Eur J Nucl Med 28 (2001) 816-821
5. Kubota K., Yokoyama J., Yamaguchi K., et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT. Eur J Nucl Med Mol Imaging 31 (2004) 590-595
6. Lapela M., Eigtved A., Jyrkkio S., et al. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 36 (2000) 858-867
7. Lee J.C., Kim J.S., Lee J.H., et al. F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma. Oral Oncol (2006) 15
8. 18F-FDG PET and CT in Patients with Head and Neck Cancer. J Nucl Med 47 (2006) 256-261
9. Schwartz D.L., Rajendran J., Yueh B., et al. Staging of head and neck squamous cell cancer with extended-field FDG-PET. Arch Otolaryngol Head Neck Surg 129 (2003) 1173-1178
10. Clavo A.C., and Wahl R.L. Effects of hypoxia on the uptake of tritiated thymidine, L-leucine, L-methionine and FDG in cultured cancer cells. J Nucl Med 37 (1996) 502-506
11. Cook G.J., Maisey M.N., and Fogelman I. Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine. Eur J Nucl Med 26 10 (1999) 1363-1378 October
12. 67Ga-citrate, and 125I-HSA. Eur J Nucl Med 26 4 (1999) 333-341 April
13. 11C-methionine PET, correlation with morphologic response, and clinical outcome. J Nucl Med 44 (2003) 526-532
14. Kubota K., Ishiwata K., Kubota R., et al. Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67. J Nucl Med 32 (1991) 2118-2123
15. Leskinen-Kallio S., Nagren K., Lehikoinen P., Ruotsalainen U., Teras M., and Joensuu H. Carbon-11-methionine and PET is an effective method to image head and neck cancer. J Nucl Med 33 (1992) 691-695
16. Lindholm P., Leskinen S., and Lapela M. Carbon-11-methionine uptake in squamous cell head and neck cancer. J Nucl Med 39 (1998) 1393-1397
17. 11C]methionine-positron emission tomography. Radiother Oncol 52 (1999) 225-232
18. 11C-methionine PET as a marker for the radiosensitivity of low-grade gliomas. Eur J Nucl Med Mol Imaging 29 (2002) 632-640
19. Nuutinen J., Sonninen P., Lehikoinen P., et al. Radiotherapy treatment planning and long-term follow-up with [(11)C]methionine PET in patients with low-grade astrocytoma. Int J Radiat Oncol Biol Phys 48 (2000) 43-52
20. Geets X., Daisne J.F., Gregoire V., et al. Role of 11-C methionine positron emission tomography for the delination of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT. Radiother Oncol 71 (2004) 267-273
21. Kim H.J., Boyd J., Dunphy F., and Lowe V. F-18 FDG PET scan after radiotherapy for early-stage larynx cancer. Clin Nucl Med JID - 7611109 23 (1998) 750-752
22. Kitagawa Y., Sadato N., Azuma H., et al. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms. J Nucl Med 40 (1999) 1132-1137
23. Kubota R., Kubota K., Yamada S., et al. Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 36 (1995) 484-492
24. Kubota R., Yamada S., Kubota K., Ishiwata K., Tamahashi N., and Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33 (1992) 1972-1980
25. 11C-tyrosine PET in patients with laryngeal carcinomas: comparison of standardized uptake value and protein synthesis rate. J Nucl Med 44 (2003) 341-346
26. De Boer J.R., Van Der Laan B.F., Pruim J., et al. Carbon-11 tyrosine PET for visualization and protein synthesis rate assessment of laryngeal and hypopharyngeal carcinomas. Eur J Nucl Med Mol Imaging 29 (2002) 1182-1187
27. 11C. Eur J Nucl Med 1 (1976) 11-14